CGMP

Results: 141



#Item
21CMC Biologics Achieves Authorization for cGMP Commercial Manufacturing by the Danish Medicines Agency Copenhagen biopharmaceutical manufacturing facility expanded to support growing customer demand for clinical and comme

CMC Biologics Achieves Authorization for cGMP Commercial Manufacturing by the Danish Medicines Agency Copenhagen biopharmaceutical manufacturing facility expanded to support growing customer demand for clinical and comme

Add to Reading List

Source URL: www.cmcbio.com

Language: English - Date: 2014-06-06 19:26:20
    22Microsoft Word - cGMP facility.doc

    Microsoft Word - cGMP facility.doc

    Add to Reading List

    Source URL: www.saltstick.com

    - Date: 2008-05-30 02:08:07
      23Special Feature  Nippon Shinyaku Launches Zalutia®, a Breakthrough New Drug for Urinary Disorders Caused by Benign Prostatic Hypertrophy Benign prostatic hypertrophy, or BPH, negatively affects a patient’s quality of

      Special Feature Nippon Shinyaku Launches Zalutia®, a Breakthrough New Drug for Urinary Disorders Caused by Benign Prostatic Hypertrophy Benign prostatic hypertrophy, or BPH, negatively affects a patient’s quality of

      Add to Reading List

      Source URL: www.nippon-shinyaku.co.jp

      Language: English - Date: 2014-11-10 02:30:14
      24VIAGRA® (sildenafil citrate) Tablets DESCRIPTION VIAGRA®, an oral therapy for erectile dysfunction, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodies

      VIAGRA® (sildenafil citrate) Tablets DESCRIPTION VIAGRA®, an oral therapy for erectile dysfunction, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodies

      Add to Reading List

      Source URL: www.accessdata.fda.gov

      Language: English - Date: 2010-01-20 12:05:19
      25The cost-utility of Viagra® in The Netherlands *Elly A. Stolk, M.Sc.1 Jan J. V Busschbach, Ph.D.1 Max Caffa, M.D.2

      The cost-utility of Viagra® in The Netherlands *Elly A. Stolk, M.Sc.1 Jan J. V Busschbach, Ph.D.1 Max Caffa, M.D.2

      Add to Reading List

      Source URL: www.bmg.eur.nl

      Language: English - Date: 2010-07-20 09:36:51
      26Karessa Pharma Holding AB (publ) Company Description for listing on Nasdaq Stockholm First North February 2015

      Karessa Pharma Holding AB (publ) Company Description for listing on Nasdaq Stockholm First North February 2015

      Add to Reading List

      Source URL: karessa.se

      Language: English - Date: 2015-02-18 05:34:46
      27Microsoft Word - KWB 2009_2.doc

      Microsoft Word - KWB 2009_2.doc

      Add to Reading List

      Source URL: www.lareb.nl

      Language: English
      28LSNE Contract Manufacturing offers a full range of development services in our cGMP facility located in Bedford, New Hampshire.

      LSNE Contract Manufacturing offers a full range of development services in our cGMP facility located in Bedford, New Hampshire.

      Add to Reading List

      Source URL: www.lyophilization.com

      Language: English - Date: 2013-01-25 02:42:59
      29LSNE Contract Manufacturing has two cGMP facilities located in New Hampshire, capable of producing parenteral material for toxicology lots, clinical trials and commercial use.

      LSNE Contract Manufacturing has two cGMP facilities located in New Hampshire, capable of producing parenteral material for toxicology lots, clinical trials and commercial use.

      Add to Reading List

      Source URL: www.lyophilization.com

      Language: English - Date: 2013-01-25 02:42:44
      30LSNE Contract Manufacturing is a recognized cGMP lyophilization service provider, dedicated to producing quality products and offering timely service.

      LSNE Contract Manufacturing is a recognized cGMP lyophilization service provider, dedicated to producing quality products and offering timely service.

      Add to Reading List

      Source URL: www.lyophilization.com

      Language: English - Date: 2013-01-25 02:42:49